Testing a new heart bypass graft in people needing multi-vessel CABG
Part of Heart & circulation clinical trials.
This study tests a new way to connect a bypass graft during heart bypass surgery for people with blocked heart arteries. The goal is to see if the new graft can be safely placed and works well enough to improve outcomes compared with the standard approach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and expected to live at least 2 years
- You are scheduled for elective (planned) bypass surgery for multiple blocked heart vessels
- Your surgeon plans a left internal mammary artery (LIMA) graft to your LAD artery and it is feasible
- The target artery has a blockage or very tight narrowing and is large enough (at least 2 mm) with good blood flow beyond the blockage
- You can agree to the study and allow follow-up scans and a heart catheter test (coronary angiogram)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a lab-made blood vessel (called an ATEV) used as a bypass graft during heart surgery. The ATEV is designed for people who don't have enough healthy leg vein for standard bypass grafts, and it may help restore blood flow to the heart more safely.
This trial tests a new device called Elana for heart bypass surgery. It may help people who need multiple bypass grafts, including one to the left front artery of the heart.
This trial compares two types of heart bypass surgery for people with blockages in three main heart arteries. It tests a hybrid approach that combines a small incision bypass with a stent, versus a standard off-pump bypass. This may mean less recovery time for some patients.
This trial tests a new artificial blood vessel for heart bypass surgery. If you need a bypass and meet the health requirements, you may be able to receive this experimental graft.
This study compares two types of heart bypass surgery for people with blockages in multiple heart arteries: a newer, less invasive technique (minimally invasive CABG) versus the traditional open-chest approach. It aims to see which approach leads to better recovery and outcomes.
This trial tests a man-made blood vessel (CTEV) as a new option for bypass grafts in people who need heart bypass surgery. It aims to see if the CTEV is safe and effective for improving blood flow to the heart.
Hear when a new Multi Vessel Coronary Artery Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.